Replies to post #4989 on Dendreon Corp fka DNDNQ

[walldiver]

Correct, but will the company announce the TTP data? I would hope so, but also remember that TTP is sort of a crapshoot...and do we know the measurement intervals this time? Because it's possible that its importance will be de-emphasized by the investigators due to it not being the primary endpoint.

[croumagnon]

"Don't forget that the TTP data will be available at the interim too."

Shouldn't TTP be available much sooner than that? Based on what we saw in 9901 and 9902a, I thought TTP occurence was of the order of 10 weeks or so past infusion. Could we not see a TTP announcement in early 2008?

As to the importance of TTP, this is bound to be an embarrasing case for the FDA if it comes out very statistically significant because many of the naysayer's arguments previously were that Provenge missed its TTP priomary endpoint. I know it is not a primary endpoint for this particular trial, nevertheless I wonder how it will be dealt with by the naysayers and by the FDA in case we get very good TTP results...